BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15191666)

  • 1. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
    Zhang TY; An JL; Gu JY; He S
    Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
    Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
    Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
    Cheng LM; Wang SY; Lin JS
    Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
    Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between PTEN and VEGF expression and clinicopathological characteristics in HCC.
    Mi D; Yi J; Liu E; Li X
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):682-5. PubMed ID: 17357488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PTEN expression and its significance in human primary hepatocellular carcinoma].
    Wan XW; Wang HY; Jiang M; He YQ; Liu SQ; Cao HF; Qiu XH; Tang L; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):490-2. PubMed ID: 12939185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and significance of new tumor suppressor gene PTEN in primary liver cancer.
    Dong-Dong L; Xi-Ran Z; Xiang-Rong C
    J Cell Mol Med; 2003; 7(1):67-71. PubMed ID: 12767263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
    Li Q; Xu B; Fu L; Hao XS
    J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between the expression of PTEN protein and phosphorylation of MAPK in hepatocellular carcinomas and their surrounding liver tissues].
    Feng DY; Cheng RX; Zheng H
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):117-20. PubMed ID: 12575334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
    Vizio B; Bosco O; David E; Caviglia GP; Abate ML; Schiavello M; Pucci A; Smedile A; Paraluppi G; Romagnoli R; Lupia E; Bellone G; Montrucchio G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of PTEN-encoding product in different stages of carcinogenesis and progression of gastric carcinoma].
    Zheng HC; Chen Y; Kuang LG; Yang L; Li JY; Wu DY; Zhang SM; Xin Y
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):13-6. PubMed ID: 12678979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
    Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
    Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer.
    Zhou YJ; Xiong YX; Wu XT; Shi D; Fan W; Zhou T; Li YC; Huang X
    World J Gastroenterol; 2004 Nov; 10(21):3225-9. PubMed ID: 15457582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
    Zhao A; Dou K; Li K; Fu Y
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of epithelial-cadherin, CD44v6 and connexin43 in hepatocellular carcinoma].
    Zhang BY; Dai XW; Chen QY; Fang L; Qian B; Sun GY; Cui HH
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):616-9. PubMed ID: 17134571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma.
    Yang L; Kuang LG; Zheng HC; Li JY; Wu DY; Zhang SM; Xin Y
    World J Gastroenterol; 2003 Jan; 9(1):35-9. PubMed ID: 12508347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.